Amgen Beneish M-Score Historical Data
The historical data trend for Amgen's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amgen Beneish M-Score Chart
|
Amgen Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Beneish M-Score |
|
Get a 7-Day Free Trial
|
|
|
-2.18 |
-2.67 |
-2.36 |
-2.61 |
-2.44 |
|
Amgen Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Beneish M-Score |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
-2.61 |
-2.61 |
-2.75 |
-2.72 |
-2.44 |
Competitive Comparison of Amgen's Beneish M-Score
For the Drug Manufacturers - General subindustry, Amgen's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amgen's Beneish M-Score Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amgen's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Amgen's Beneish M-Score falls into.
Amgen Beneish M-Score Calculation
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Amgen for today is based on a combination of the following eight different indices:
| M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
| = | -4.84 | + | 0.92 * 1.1602 | + | 0.528 * 1.0806 | + | 0.404 * 1.088 | + | 0.892 * 1.0709 | + | 0.115 * 0.9502 |
| - | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI |
| - | 0.172 * 1.0657 | + | 4.679 * -0.047214 | - | 0.327 * 1.0307 |
| = | -2.44 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| This Year (Dec23) TTM: | Last Year (Dec22) TTM: |
Total Receivables was $7,942 Mil.
Revenue was 8196 + 6903 + 6986 + 6105 = $28,190 Mil.
Gross Profit was 5084 + 5097 + 5173 + 4385 = $19,739 Mil.
Total Current Assets was $30,332 Mil.
Total Assets was $97,154 Mil.
Property, Plant and Equipment(Net PPE) was $5,941 Mil.
Depreciation, Depletion and Amortization(DDA) was $4,071 Mil.
Selling, General, & Admin. Expense(SGA) was $6,179 Mil.
Total Current Liabilities was $18,392 Mil.
Long-Term Debt & Capital Lease Obligation was $63,170 Mil.
Net Income was 767 + 1730 + 1379 + 2841 = $6,717 Mil.
Non Operating Income was 402 + 685 + -318 + 2064 = $2,833 Mil.
Cash Flow from Operations was 538 + 2760 + 4109 + 1064 = $8,471 Mil.
|
Total Receivables was $6,392 Mil.
Revenue was 6839 + 6652 + 6594 + 6238 = $26,323 Mil.
Gross Profit was 5092 + 5064 + 5084 + 4677 = $19,917 Mil.
Total Current Assets was $22,186 Mil.
Total Assets was $65,121 Mil.
Property, Plant and Equipment(Net PPE) was $5,427 Mil.
Depreciation, Depletion and Amortization(DDA) was $3,417 Mil.
Selling, General, & Admin. Expense(SGA) was $5,414 Mil.
Total Current Liabilities was $15,687 Mil.
Long-Term Debt & Capital Lease Obligation was $37,354 Mil.
|
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
| DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
| = | (7942 / 28190) | / | (6392 / 26323) |
| = | 0.281731 | / | 0.242829 |
| | = | 1.1602 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
| GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
| = | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) |
| = | (19917 / 26323) | / | (19739 / 28190) |
| = | 0.756639 | / | 0.700213 |
| | = | 1.0806 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
| AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
| = | (1 - (30332 + 5941) / 97154) | / | (1 - (22186 + 5427) / 65121) |
| = | 0.626644 | / | 0.575974 |
| | = | 1.088 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
| SGI | = | Sales_t | / | Sales_t-1 |
| = | Revenue_t | / | Revenue_t-1 |
| = | 28190 | / | 26323 |
| | = | 1.0709 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
| DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
| = | (3417 / (3417 + 5427)) | / | (4071 / (4071 + 5941)) |
| = | 0.386364 | / | 0.406612 |
| | = | 0.9502 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
| SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
| = | (6179 / 28190) | / | (5414 / 26323) |
| = | 0.219191 | / | 0.205676 |
| | = | 1.0657 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
| LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
| = | ((63170 + 18392) / 97154) | / | ((37354 + 15687) / 65121) |
| = | 0.839513 | / | 0.814499 |
| | = | 1.0307 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
| TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (6717 - 2833 | - | 8471) | / | 97154 |
| | = | -0.047214 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Amgen has a M-score of -2.44 suggests that the company is unlikely to be a manipulator.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0R0T has been successfully added to your